Self-Driving Cars the Focus of Latest Report from the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Self-Driving Cars the Focus of Latest Report from the National Council on Disability

WASHINGTON, Nov. 2, 2015 (GLOBE NEWSWIRE) -- On Monday, November 2, the National Council on Disability (NCD)—an independent federal agency that advises the President, Congress and other federal agencies on disability policy—will release "Self Driving Cars: Mapping Access to a Technology Revolution" at its quarterly meeting in Concord, NH with a brief summary of the report's findings and recommendations. The new report maps out the emerging revolution in transportation technology and explores the ways these advances have the potential to increase independence for people with disabilities, along with an examination of the various roadblocks that may be encountered en route to that destination. The report evaluates current technology, regulatory considerations, and obstacles both scientific and political; and provides recommendations for preventing or eliminating barriers, including model legislative language.

DATE: Monday, November 2, 2015

TIME: 11 am – 11:30 am ET

LOCATION: Capitol Center for the Arts, Governors Hall, 44 South Main Street, Concord, NH 03301

"Adopting the recommendations offered by NCD will ensure that people with disabilities are not left at the side of the road as self-driving technology is developed and advanced," said Clyde Terry, NCD Chair. "All Americans, including people with disabilities, should have an equal opportunity to benefit from and realize the freedom that fully autonomous vehicles promise to provide."

"The Council looks forward to working with the Administration, Congress, automobile manufacturers and innovators in the tech industry to ensure that people with disabilities have a role in both helping develop and to realize the maximum benefits possible from these exciting and emerging advances," added Janice Lehrer-Stein, NCD Councilmember who spearheaded the report.

Key recommendations of the report include:

  • Funding proposals for the research or development of autonomous vehicles should include accessibility requirements for people with disabilities, including compliance with Section 508 of the Rehabilitation Act.
  • Licensing at the state level should include national guidelines developed by the United States Department of Transportation. These should not impose undue or unnecessary limits on people with disabilities.
  • Congress should pass legislation requiring full disability access for all types of common and public use autonomous vehicles developed and informed, to a large degree, with the input and guidance of manufacturers, an appropriate disability advisory committee, and the National Highway Traffic Safety Administration.
  • Congress should expressly forbid discrimination on the basis of disability by states or any other government authority in licensing, and should withhold federal highway funds to states that do not comply, a practice that would parallel existing reasonable legal drinking age restrictions.

A digital copy of the report can be read or downloaded from NCD's website online: http://www.ncd.gov/publications/2015/self-dri...revolution

About the National Council on Disability (NCD): First established as an advisory Council within the Department of Education in 1978, NCD became an independent federal agency in 1984. In 1986, NCD recommended enactment of an Americans with Disabilities Act (ADA), and drafted the first version of the bill which was introduced in the House and Senate in 1988. Since enactment of the ADA in 1990, NCD has continued to play a leading role in crafting disability policy, and advising the President, Congress and other federal agencies on disability policies, programs, and practices.

Lawrence Carter-Long Public Affairs Specialist National Council on Disability 1331 F Street, NW, Suite 850 Washington, DC 20004 347-337-2249 CELL 202-272-2074 TTY 202-272-2022 Fax

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading